Home » Topics » Regulatory » Patents

Patents
RSS

New antitumor compounds presented by Kyorin

Dec. 15, 1998

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

Dec. 15, 1998

Another series of adenosine kinase inhibitors patented by Abbott

Dec. 11, 1998

Noninfectious HIV particles as immunogens for treating or preventing HIV infection/AIDS

Dec. 11, 1998

Adenosine absorption inhibitors from Kyowa Hakko useful as antiinflammatories, cardioprotectants

Dec. 11, 1998

Quinolinomorphinans for ischemic, hemorrhagic, traumatic or degenerative brain disorders

Dec. 11, 1998

Orally bioavailable anti-HIV peptides described in patent literature by Japan Energy

Dec. 10, 1998

Wide series of adenosine kinase inhibitors undergoing evaluation at Abbott

Dec. 10, 1998

New antitumor series developed at Daiichi

Dec. 10, 1998

Carbostyril compounds useful for arteriosclerosis and thrombosis

Dec. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...